Safety of a proteoliposome from Neisseria meningitides as adjuvant for a house dust mite allergy vaccine-Reference-Cited by-同舟云学术

Safety of a proteoliposome from Neisseria meningitides as adjuvant for a house dust mite allergy vaccine

Published:2017-01-01 Issue:1 Volume:14 Page:152-159
ISSN:1547-691X
Container-title:Journal of Immunotoxicology
language:en
Short-container-title:Journal of Immunotoxicology

Author:

Ramírez Wendy¹,Bourg Virgilio¹,Torralba Damaris¹,Facenda Elisa¹,Tamargo Beatriz²,González Bárbara O.³,Sierra Gustavo⁴,Pérez Oliver⁴,Perez-Llano Yordanis⁵,Labrada Alexis¹

Affiliation:

1. Allergens Department, Centro Nacional de Biopreparados, Bejucal, Mayabeque, Cuba;

2. Pharmacy and Food Institute, University of Havana, Havana, Cuba;

3. CENPALAB, Mayabeque, Cuba;

4. FINLAY Institute, Havana, Cuba;

5. Faculty of Biology, University of Havana, Havana, Cuba

Publisher

Informa UK Limited

Subject

Toxicology,Immunology

Link

https://tandfonline.com/doi/pdf/10.1080/1547691X.2017.1346007

Reference30 articles.

1. Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL®) adjuvant: a new allergy vaccine for dust mite allergy

2. Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A(MPL®) for the treatment of grass pollen allergy

3. Pollinex® Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of ragweed pollen allergy

4. Endotoxin Exposure during Sensitization to Blomia tropicalis Allergens Shifts TH2 Immunity Towards a TH17-Mediated Airway Neutrophilic Inflammation: Role of TLR4 and TLR2

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposome-based vaccines for minimally or noninvasive administration: an update on current advancements;Expert Opinion on Drug Delivery;2023-11-02

2. Immunogenicity of a novel anti-allergic vaccine based on house dust mite purified allergens and a combination adjuvant in a murine prophylactic model;Frontiers in Allergy;2022-11-17

3. Protective effects of Surfacen® in allergen-induced asthma mice model;International Immunopharmacology;2022-01

4. Immunogenicity of a Novel Anti-Allergic Vaccine Based on Purified Allergens from House Dust Mite and a Combination Adjuvant in a Murine Prophylactic Model;SSRN Electronic Journal;2022

5. Immunotherapy in allergic diseases — improved understanding and innovation for enhanced effectiveness;Current Opinion in Immunology;2020-10